. home.aspx



MIT Targets Life Sciences with Clinical Trial Analytics Project

January 09, 2019 / Jessica Kent

The MIT Laboratory for Financial Engineering (LFE) and Informa Pharma Intelligence have launched an initiative to provide timely and accurate estimates of the risks and benefits of clinical trials to the entire life sciences ecosystem. Project ALPHA (Analytics for Life-sciences Professionals and Healthcare Advocates) aims to help investors, payers, regulators, and biopharmaceutical companies better evaluate the opportunities of biomedical research and development. Project ALPHA’s first project will be the further development of clinical success rate metrics, based on algorithms developed by MIT researchers and published in Biostatistics in January. The article discusses Informa’s Citeline drug and clinical trial datasets and evaluates clinical success from pre-clinical to launch across nine therapeutic groups, offering the most comprehensive assessment on clinical success rates ever published. LFE and Informa jointly developed the metrics, which will be made freely availabl...